| Differential expressions of PD-1, PD-L1 and PD-L2 between primary and metastatic sites in renal cell carcinoma X Zhang, X Yin, H Zhang, G Sun, Y Yang, J Chen, X Zhu, P Zhao, J Zhao, ... BMC cancer 19, 1-10, 2019 | 88 | 2019 |
| Integrated molecular characterization of fumarate hydratase–deficient renal cell carcinoma G Sun, X Zhang, J Liang, X Pan, S Zhu, Z Liu, CM Armstrong, J Chen, ... Clinical Cancer Research 27 (6), 1734-1743, 2021 | 75 | 2021 |
| Integrated exome and RNA sequencing of TFE3-translocation renal cell carcinoma G Sun, J Chen, J Liang, X Yin, M Zhang, J Yao, N He, CM Armstrong, ... Nature communications 12 (1), 5262, 2021 | 74 | 2021 |
| The efficacy and safety of radical prostatectomy and radiotherapy in high-risk prostate cancer: a systematic review and meta-analysis Z Wang, Y Ni, J Chen, G Sun, X Zhang, J Zhao, X Zhu, H Zhang, S Zhu, ... World journal of surgical oncology 18, 1-13, 2020 | 55 | 2020 |
| AKR1C3 expression in primary lesion rebiopsy at the time of metastatic castration‐resistant prostate cancer is strongly associated with poor efficacy of abiraterone as a first … J Zhao, M Zhang, J Liu, Z Liu, P Shen, L Nie, W Guo, D Cai, J Liu, ... The Prostate 79 (13), 1553-1562, 2019 | 33 | 2019 |
| Pelvic lymph node dissection and its extent on survival benefit in prostate cancer patients with a risk of lymph node invasion> 5%: a propensity score matching analysis from … J Chen, Z Wang, J Zhao, S Zhu, G Sun, J Liu, H Zhang, X Zhang, P Shen, ... Scientific Reports 9 (1), 17985, 2019 | 32 | 2019 |
| The prognostic value of the proportion and architectural patterns of intraductal carcinoma of the prostate in patients with de novo metastatic prostate cancer J Zhao, J Liu, G Sun, M Zhang, J Chen, P Shen, Z Liu, B Liao, X Zhang, ... The Journal of urology 201 (4), 759-768, 2019 | 31 | 2019 |
| Comparison of current systemic combination therapies for metastatic hormone-sensitive prostate cancer and selection of candidates for optimal treatment: a systematic review and … J Chen, Y Ni, G Sun, B Liao, X Zhang, J Zhao, S Zhu, Z Wang, P Shen, ... Frontiers in Oncology 10, 519388, 2020 | 28 | 2020 |
| Homologous recombination deficiency (HRD) score in aggressive prostatic adenocarcinoma with or without intraductal carcinoma of the prostate (IDC-P) S Zhu, J Zhao, L Nie, W Yin, Y Zhang, F Zhao, Y Ni, X Zhang, Z Wang, ... BMC medicine 20 (1), 237, 2022 | 25 | 2022 |
| Circulating tumour DNA reveals genetic traits of patients with intraductal carcinoma of the prostate J Zhao, G Sun, S Zhu, J Dai, J Chen, M Zhang, Y Ni, H Zhang, P Shen, ... BJU international 129 (3), 345-355, 2022 | 24 | 2022 |
| The adiponectin-AdipoR1 axis mediates tumor progression and tyrosine kinase inhibitor resistance in metastatic renal cell carcinoma G Sun, X Zhang, Z Liu, S Zhu, P Shen, H Zhang, M Zhang, N Chen, ... Neoplasia 21 (9), 921-931, 2019 | 22 | 2019 |
| Dynamic multidisciplinary team discussions can improve the prognosis of metastatic castration‐resistant prostate cancer patients S Zhu, J Chen, Y Ni, H Zhang, Z Liu, P Shen, G Sun, J Liang, X Zhang, ... The Prostate 81 (11), 721-727, 2021 | 21 | 2021 |
| What kind of patients with castration-naïve prostate cancer can benefit from upfront docetaxel and abiraterone: A systematic review and a network meta-analysis G Sun, X Zhang, J Chen, B Liao, Z Liu, J Zhao, AC Gao, Y Yang, K Shu, ... Urologic Oncology: Seminars and Original Investigations 36 (12), 505-517, 2018 | 20 | 2018 |
| Novel nomograms for castration‐resistant prostate cancer and survival outcome in patients with de novo bone metastatic prostate cancer J Zhao, G Sun, B Liao, X Zhang, CM Armstrong, X Yin, J Liu, J Chen, ... BJU international 122 (6), 994-1002, 2018 | 20 | 2018 |
| Assessment for prognostic value of differentially expressed genes in immune microenvironment of clear cell renal cell carcinoma X Yin, X Zhang, Z Liu, G Sun, X Zhu, H Zhang, S Zhu, J Zhao, J Chen, ... American journal of translational research 12 (9), 5416, 2020 | 17 | 2020 |
| Comparison of the prognosis of primary and progressive muscle-invasive bladder cancer after radical cystectomy: A systematic review and meta-analysis J Chen, H Zhang, G Sun, X Zhang, J Zhao, J Liu, P Shen, M Shi, H Zeng International Journal of Surgery 52, 214-220, 2018 | 16 | 2018 |
| Improved long-term clinical outcomes and safety profile of sunitinib dosing schedule with 4/2 switched to 2/1 in patients with metastatic renal cell carcinoma X Zhang, G Sun, J Zhao, K Shu, P Zhao, J Liu, Y Yang, Q Tang, J Chen, ... Journal of Cancer 9 (18), 3303, 2018 | 16 | 2018 |
| Intraductal carcinoma of the prostate in prostate biopsy samples: correlation with aggressive pathological features after radical prostatectomy and prognostic value in high … S Zhu, JG Zhao, JR Chen, ZH Liu, GX Sun, ZP Wang, YC Ni, JD Dai, ... Asian journal of andrology 22 (5), 519-525, 2020 | 15 | 2020 |
| The clinical significance of perineural invasion in patients with de novo metastatic prostate cancer J Zhao, J Chen, M Zhang, X Tang, G Sun, S Zhu, J Liu, H Zhang, X Zhang, ... Andrology 7 (2), 184-192, 2019 | 14 | 2019 |
| Multidisciplinary Team (MDT) discussion improves overall survival outcomes for metastatic renal cell carcinoma patients Y Zeng, S Zhu, Z Wang, J Chen, J Dai, Z Liu, G Sun, J Liang, X Zhang, ... Journal of multidisciplinary healthcare, 503-513, 2023 | 13 | 2023 |
